Treace Medical Concepts, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
TMCI on Nasdaq
Location
100 Palmetto Park Place, Ponte Vedra, FL

Insiders trading volume in the past year

Treace Medical Concepts, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John Treace Chief Executive Officer, Director, 10%+ Owner $106M +$524K +0.5% Mar 8, 2025
John R. Treace Director $59.2M May 9, 2022
Thomas Timbie Director $40.1M Mar 15, 2023
Joe W. Ferguson SVP, Research & Development $13.4M Oct 6, 2021
James Treace Director $10.6M Aug 15, 2024
Jaime Frias Chief Legal Officer $7.32M Mar 8, 2022
Richard W. Mott Director $7.31M May 20, 2025
Scot Elder Chief Legl & Comp Off, CorpSec $3.68M Oct 25, 2025
John K. Bakewell Director $3.44M May 20, 2025
Mark Hair Chief Financial Officer $3.05M Aug 9, 2025
Guy Guglielmino Chief Commercial Officer $3.01M Dec 1, 2024
Sean Scanlan Chief Innovation Officer $2.51M -$398K -13.7% Oct 24, 2025
Aaron Berutti SVP, Sales $1.21M Aug 9, 2025
Daniel E. Owens Chief Human Resources Officer $820K Mar 15, 2023
Deepti Jain Director $468K May 20, 2025
Jane E. Kiernan Director $426K May 20, 2025
Betsy Hanna Director $301K May 20, 2025
Lance A. Berry Director $297K May 20, 2025
Lawrence Hamilton Director $293K May 20, 2025
Terry W. Lubben SVP, Operations $155K Mar 8, 2022
F. Barry Bays Former Director Jun 2, 2023

Recent Insider Transactions by Companies or Individuals for Treace Medical Concepts, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.